← brief for 2026-08-31 · Transplant & xeno

Cardio-renal protection of MRAs in kidney-transplanted diabetic patients.

Key takeaways

This is a review of a drug family called MRAs for people who have had a kidney transplant and also have diabetes. Transplanted kidneys often scar and slowly lose function over the years, and heart disease is common in the same patients. The authors argue that blocking this hormone pathway could lower inflammation, cell stress, and scarring in both the heart and the kidney. It is a review of existing work, not a new trial, so there are no new results here.

Who did this work

El Essawy B · Safa K · Al-Dalbhi S · Chandraker AK

Source

Article · PubMed, Losartan and CKD, long-term use · 2026 Aug 30
https://pubmed.ncbi.nlm.nih.gov/42669336/